SLDB · Solid Biosciences Inc. · Executive Compensation
$6.25
-0.19 (-2.95%)
At close · Nov 20
Return incl. dividend (before tax)
Q1 2022 earnings call transcript
Market Cap
$697.57M
Shares
111.61M
Volume · Nov 20
1.56M
Avg daily vol (3M)
1.29M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Alexander (Bo) Cumbo | President and Chief Executive Officer | $5,223,442 |
| David Tyronne Howton | Chief Operating Officer and Secretary | $2,588,827 |
| Gabriel Brooks | M.D., Chief Medical Officer | $2,328,156 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Alexander (Bo) Cumbo | President and Chief Executive Officer | $4,869,909 |
| David Tyronne Howton | Chief Operating Officer and Secretary | $2,563,014 |
| Gabriel Brooks | M.D., Chief Medical Officer | $2,071,372 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Carl Morris | Ph.D., Former Chief Scientific Officer, Neuromuscular | $1,559,449 |
| Kevin Tan | Chief Financial Officer | $1,346,305 |
| Alexander (Bo) Cumbo | President and Chief Executive Officer | $918,630 |
| David Tyronne Howton | Chief Operating Officer and Secretary | $648,880 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Ilan Ganot | Former President and Chief Executive Officer | $2,205,508 |
| Alexander (Bo) Cumbo | President and Chief Executive Officer | $2,200,212 |
| Erin Powers Brennan | Former Chief Legal Officer and Secretary | $1,339,762 |
| David Tyronne Howton | Chief Operating Officer, General Counsel and Secretary | $1,017,870 |
| Carl Morris | Ph.D., Former Chief Scientific Officer, Neuromuscular | $873,723 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Ilan Ganot | Former President and Chief Executive Officer | $3,293,809 |
| Erin Powers Brennan | Former Chief Legal Officer and Secretary | $2,878,244 |
| Joel Schneider | Ph.D., Chief Operating Officer | $1,702,761 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Ilan Ganot | President and Chief Executive Officer | $1,481,002 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Ilan Ganot | President and Chief Executive Officer | $3,335,929 |
| Jorge Quiroz | M.D., Former Chief Medical Officer | $1,541,208 |
| Alvaro Amorrortu | Former Chief Operating Officer | $1,523,308 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Ilan Ganot | President and Chief Executive Officer | $5,983,770 |
| Alvaro Amorrortu | Former Chief Operating Officer | $2,842,736 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Ilan Ganot | Class I Director | Appointed | 2026-04-10 |
| Ilan Ganot | member of the Board | Resigned | 2026-04-10 |
| Sukumar Nagendran | Class I director | Appointed | 2025-06-13 |
| Alexander Cumbo | Class I director |
Already on the board
Since at least 2022: re-election or new board role
|
2025-06-13 |
|
Rajeev Shah
“Mr. Shah's decision to resign from the Board was not due to a disagreement on any matter related to the Company's operations, policies or practices.”
|
member of the Board | Resigned | 2024-06-11 |
|
Adam Koppel
“Dr. Koppel’s decision to resign from the Board was not due to a disagreement on any matter related to the Company’s operations, policies or practices.”
|
member of the Company's Board of Directors | Resigned | 2024-06-11 |
| Lynne Sullivan | Class II director | Appointed | 2023-06-09 |
| Adam Stone | Class II director | Appointed | 2023-06-09 |
| Adam Koppel | Class II director | Appointed | 2023-06-09 |
| Clare Kahn | Class II director | Appointed | 2023-06-09 |
| Kevin Tan | principal accounting officer | Appointed | 2023-01-09 |
| Kevin Tan | Chief Financial Officer | Appointed | 2023-01-09 |
| Erin Powers Brennan | Chief Legal Officer and Secretary | Resigned | 2022-12-05 |
| Ilan Ganot | Chief Executive Officer and President | Resigned | 2022-12-05 |
| Alexander (Bo) Cumbo | President and Chief Executive Officer | Appointed | 2022-12-05 |
| Bo Cumbo | board of directors | Appointed | 2022-09-30 |
| Bo Cumbo | Chief Executive Officer | Appointed | 2022-09-30 |
| Adam Koppel | board of directors | Appointed | 2022-09-30 |
| Alexander (Bo) Cumbo | board of directors | Appointed | 2022-09-30 |
| Alexander (Bo) Cumbo | President and Chief Executive Officer | Appointed | 2022-09-30 |
| Erin Powers Brennan | Chief Legal Officer and Secretary | Resigned | 2022-09-30 |
| Ilan Ganot | Chief Executive Officer and President | Resigned | 2022-09-30 |
| Joel Schneider | Chief Operating Officer | Resigned | 2022-04-27 |
|
Matthew Arnold
“Mr. Arnold’s decision to resign from the Board was not due to a disagreement on any matter related to the Company’s operations, policies or practices.”
|
member of the Board of Directors | Resigned | 2021-06-17 |
| Georgia Keresty | member of the Board | Appointed | 2021-03-05 |
Leadership
- Alexander (Bo) Cumbo CEO, Board Member
- Bo Cumbo CEO, Board Member
- Ian F. Smith Chairman
- Kevin Tan CFO, Chief Accounting Officer
- David Tyronne Howton COO
- Joel Schneider COO
- Paul Herzich CTO
- Adam Koppel Board Member
- Adam Koppel, M.D., Ph.D. Board Member
- Adam Stone Board Member
- Clare Kahn Board Member
- Georgia Keresty Board Member
- Ian Smith Board Member
- Ilan Ganot Board Member
- Lynne Sullivan Board Member
- Martin Freed Board Member
- Sukumar Nagendran Board Member
Key facts
CIK
1707502
CUSIP
83422E204
13F (30d)
160 filings
144 filers
Visit website
Investor relations